Bayer AG Sponsored ADR (BAYA)
XDUS 
Summary
BAYA Chart
Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court
Bayer's Monsanto unit heads to a Missouri state court on Monday seeking approval of a $7.25 billion settlement that could resolve tens of thousands of U.S. lawsuits alleging that its popular weedkiller Roundup causes cancer.
Bayer Secures FDA Nod for Sevabertinib's First-Line Use in NSCLC
BAYRY's sevabertinib wins first-line NSCLC approval. The company advances BAY 3670549 into a phase II AFib study.
Bayer Aktiengesellschaft (BAYRY) Discusses Innovation Strategy and Progress on Five-Year Growth Framework in Crop Science Division Transcript
Bayer Aktiengesellschaft (BAYRY) Discusses Innovation Strategy and Progress on Five-Year Growth Framework in Crop Science Division Transcript
Bayer AG Sponsored ADR (BAYA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Bayer AG Sponsored ADR ever had a stock split?
Bayer AG Sponsored ADR Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Bill Anderson CEO | XDUS Exchange | US0727303028 ISIN |
| DE Country | 88,078 Employees | 28 Apr 2026 Last Dividend | 20 Sep 2017 Last Split | - IPO Date |
Overview
Bayer Aktiengesellschaft is a globally recognized life science company that operates worldwide with a vast array of subsidiaries. Established in 1863 and with its headquarters located in Leverkusen, Germany, the company engages in extensive research, development, and marketing activities across three major segments: Pharmaceuticals, Consumer Health, and Crop Science. Bayer's mission is to address some of the most pressing global challenges by providing innovative solutions in healthcare and agriculture. The company has fostered numerous collaborations with leading entities such as Acuitas Therapeutics, Inc., Peking University, the Swiss Tropical and Public Health Institute, bit.bio Ltd., Hologic, Inc., Twist Bioscience Corporation, and CrossBay Medical Inc., among others. These partnerships mainly focus on advancing Bayer's research initiatives in gene editing, pharmaceutical research, the development of therapeutics, and improving diagnostic solutions for diseases like breast cancer. Additionally, Bayer teams up with Thermo Fisher Scientific, further enhancing its product distribution capabilities which span wholesalers, pharmacies, supermarket chains, online retailers, hospitals, and direct sales to farmers.
Products and Services
- Pharmaceuticals Segment
This division primarily focuses on the development and sale of prescription medications in cardiology and women’s health care. It also encompasses specialty therapeutics in oncology, hematology, ophthalmology, and the burgeoning fields of cell and gene therapy. Moreover, Bayer is involved in the provision of diagnostic imaging equipment and solutions, along with contrast agents, catering to the healthcare industry's needs for precise and early disease detection.
- Consumer Health Segment
Under this segment, Bayer markets a wide array of non-prescription, over-the-counter medicines designed for self-medication and self-care. The products span various categories including nutritional supplements, allergy relief, cough and cold remedies, dermatology, pain management, cardiovascular risk prevention, and digestive health. This segment illustrates Bayer's commitment to supporting everyday health and wellness through accessible healthcare solutions.
- Crop Science Segment
This sector of Bayer’s operations is dedicated to the agricultural industry, focusing on the breeding, propagation, and production/processing of seeds. Offerings also include seed dressing technologies aimed at improving crop yields and resilience. By integrating scientific advancements into agriculture, Bayer seeks to address food security and sustainability challenges, reinforcing its role in supporting the agricultural community.
